Although the PCT cutoff of 0.5 ng/mL is commonly used, as a single point, it is not specific enough to determine bacterial co-infection in the setting of either COVID-19 or influenza, as the data demonstrate a high proportion of patients will have a procalcitonin above this level during their course of disease with either virus. The gene discussed is CALCA; the disease is COVID-19.